(Q41162196)

27 September 2017

Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases (English)

1 reference

27 September 2017

0 references

3

0 references

author name string

Christopher P Neal

1

1 reference

27 September 2017

Vaux Cairns

2

1 reference

27 September 2017

Michael J Jones

3

1 reference

27 September 2017

Muhammad M Masood

4

1 reference

27 September 2017

Gael R Nana

5

1 reference

27 September 2017

Christopher D Mann

6

1 reference

27 September 2017

Giuseppe Garcea

7

1 reference

27 September 2017

Ashley R Dennison

8

1 reference

27 September 2017

language of work or name

1 reference

26 March 2015

1 reference

27 September 2017

1 reference

27 September 2017

32

1 reference

27 September 2017

5

1 reference

27 September 2017

144

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-015-0590-2

27 September 2017

0 references

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Molecular prognostic markers in resectable colorectal liver metastases: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Role of infiltrated leucocytes in tumour growth and spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Platelets: linking hemostasis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Prognostic value of PLR in various cancers: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

The combination of platelet count and neutrophil lymphocyte ratio is a predictive factor in patients with esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0590-2

Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor

21 January 2018

1 reference

12 December 2020

Systemic inflammatory response predicts survival following curative resection of colorectal cancer

1 reference

12 December 2020

The value of the pretreatment neutrophil lymphocyte ratio vs. platelet lymphocyte ratio in predicting the long-term survival in colorectal cancer

1 reference

12 December 2020

Polymorphonuclear leukocytes increase the adhesion of circulating tumor cells to microvascular endothelium

1 reference

12 December 2020

Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer

1 reference

12 December 2020

A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study

1 reference

12 December 2020

Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie

1 reference

12 December 2020

The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer

1 reference

12 December 2020

Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma

1 reference

12 December 2020

10.1007/S12032-015-0590-2

Identifiers

DOI

1 reference

Dimensions Publication ID

27 September 2017

0 references

1 reference